ReseaRch Quality assuRance foR the futuRe a ... - Lund University

Panel 10 – medicine | Laboratory
c. A third obvious challenge is the departure of the director, Dr Sten
Eirik Jacobsen in 2008. From discussions with the department heads,
it became clear that an interim director was currently in place, but
that significant effort will be put into determining who should be
the future leader of this Center. This will also include advise from
the EAB appointed to the Center. It was less clear from discussions
with the Faculty leaders, whether Dr Jacobsen would be replaced
with an internal candidate or whether resources could be put together
to recruit an outside candidate, to continue to build one of the very
outstanding 6-7 year old programs at Lund University, at a time where
many other Universities are just starting to develop such programs,
and at a time where it is becoming clear that results from basic stem
cell research will likely affect clinical medicine in the not too far a
future.
d. Other external reviews have identified a number of possible
weaknesses/challenges.
• Mouse Genetics and Mouse Transgenic facility
• Molecular Biology and Developmental Biology: It has been
pointed out through external evaluations as well as by our SAB,
that not only our program, but the faculty in general must
strengthen its expertise in molecular biology and developmental
biology.
• Lack of funding of Ph.D. students
• Lack of a clear and competitive structure for career development
• ALF system for funding of translational research
• Commitments to Translational Recruitments
• Lack of external evaluation of research at the faculty
Based on the information given in the material provided for evaluation,
these are more difficult to assess, but should obviously be addressed.
298